UBS Group’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.22K | Buy |
|
|||||
|
2025
Q1 | $162 | Sell |
|
|||||
|
2024
Q4 | $1.73K | Sell |
|
|||||
|
2024
Q3 | $8.05K | Sell |
|
|||||
|
2024
Q2 | $14.7K | Buy |
|
|||||
|
2024
Q1 | $17.9K | Buy |
|
|||||
|
2023
Q4 | $2.86K | Buy |
|
|||||
|
2023
Q3 | $2.1K | Sell |
|
|||||
|
2023
Q2 | $9.77K | Sell |
|
|||||
|
2023
Q1 | $20.7K | Buy |
|
|||||
|
2022
Q4 | $1.77K | Buy |
|
|||||
|
2022
Q3 | $0 | Sell |
|
|||||
|
2022
Q2 | $180K | Buy |
|
|||||
|
2022
Q1 | $2K | Sell |
|
|||||
|
2021
Q4 | $7K | Buy |
|
|||||
|
2021
Q3 | $14K | Sell |
|
|||||
|
2021
Q2 | $41K | Buy |
|
|||||
|
2021
Q1 | $28K | Sell |
|
|||||
|
2020
Q4 | $37K | Sell |
|
|||||
|
2020
Q3 | $84K | Sell |
|
|||||
|
2020
Q2 | $123K | Buy |
|
|||||
|
2020
Q1 | $50K | Buy |
|
|||||
|
2019
Q4 | $107K | Sell |
|
|||||
|
2019
Q3 | $179K | Buy |
|
|||||
|
2019
Q2 | $112K | Sell |
|
|||||
|
2019
Q1 | $890K | Buy |
|
|||||
|
2018
Q4 | $284K | Sell |
|
|||||
|
2018
Q3 | $718K | Buy |
|
|||||
|
2018
Q2 | $315K | Buy |
|
|||||
|
2018
Q1 | $179K | Buy |
|
|||||
|
2017
Q4 | $190K | Sell |
|
|||||
|
2017
Q3 | $167K | Sell |
|
|||||
|
2017
Q2 | $178K | Buy |
|
|||||
|
2017
Q1 | $155K | Sell |
|
|||||
|
2016
Q4 | $131K | Sell |
|
|||||
|
2016
Q3 | $186K | Sell |
|
|||||
|
2016
Q2 | $252K | Sell |
|
|||||
|
2016
Q1 | $1.36M | Buy |
|
|||||
|
2015
Q4 | $2.15M | Buy |
|
|||||
|
2015
Q3 | $1.19M | Sell |
|
|||||
|
2015
Q2 | $1.63M | Buy |
|
|||||
|
2015
Q1 | $19K | Sell |
|
|||||
|
2014
Q4 | $47K | Buy |
|